Pharmaceutical - Antibiotics and Infectious diseases, Vaccines


Popular Filters

Positive top-line results for Pfizer’s Prevenar 13 in pneumonia in over 65s


US pharma behemoth Pfizer says that top-line results from a study of Prevenar 13 (pneumococcal 13-valent…

Antibiotics and Infectious diseasesPfizerPharmaceuticalPrevenarResearchVaccines

Leading Chinese hepatitis B vaccine makers stop production; Pfizer drug import halted


China’s Food and Drug Administration announced on January 2 that the country’s three leading manufacturers…

Anti-viralsAntibiotics and Infectious diseasesAsia-PacificBioKangtaiChinaFluconazolePfizerPharmaceuticalRegulationVaccines

ProJect Pharma and TUM-spin-off link on H. pylori vaccine development


Germany-based ProJect Pharmaceutics has signed a development agreement with ImevaX, a spin-off project…

Antibiotics and Infectious diseasesImevaXLicensingPharmaceuticalProJect PharmaceuticsResearchVaccines

Infectious disease treatments market driven by growth in middle-income to low-income countries


The infectious disease treatments market increased at a compound annual growth rate (CAGR) of 6.9% between…

Antibiotics and Infectious diseasesGlobalMarkets & MarketingPharmaceuticalVaccines

GlaxoSmithKline and Abbott to start production in Ukraine


UK pharma giant GlaxoSmithKline (LSE: GSK) and the USA's Abbott (NYSE: ABT) are considering launching…

Anti-viralsAntibiotics and Infectious diseasesEuropeGlaxoSmithKlineIndarPharmaceuticalProductionVaccines

Riboxx Pharma links with China National Biotec to evaluate Riboxxim as adjuvant in a vaccine


Germany's Riboxx Pharmaceuticals GmbH and China National Biotec Group (CNBG) say they have initiated…

Antibiotics and Infectious diseasesChina National BiotecPharmaceuticalResearchRiboxx PharmaceuticalsRiboxximVaccines

NeRRe Therapeutics created to develop NRAs from GSK; GlycoVaxyn deal with GSK


NeRRe Therapeutics was launched in the UK yesterday to develop a portfolio of clinical and pre-clinical…

Antibiotics and Infectious diseasesBiotechnologyFinancialGlaxoSmithKlineGlycoVaxynLicensingNeRReTherapeuticsNeurologicalNovo NordiskPharmaceuticalResearchVaccines

Further initiatives from GlaxoSmithKline to help tackle global health challenges; TB deal with Aeras


UK pharma giant GlaxoSmithKline (LSE: GSK) yesterday announced new measures to further advance its commitment…

Antibiotics and Infectious diseasesGlaxoSmithKlineGlobalHealthcarePharmaceuticalResearchVaccines

Single silk device can store and deliver vaccine or antibiotic without costly cold chain


Researchers at the USA-based Tufts University School of Engineering have discovered a way to maintain…

Antibiotics and Infectious diseasesPharmaceuticalResearchVaccines

Daiichi Sankyo and Terumo link up for vaccine development


Drug major Daiichi Sankyo (TYO: 4568) and fellow Japanese company Terumo Corp (TYO: 4543) have entered…

Antibiotics and Infectious diseasesDaiichi SankyoPharmaceuticalResearchTerumoVaccines

Back to top